Work

Camidanlumab tesirine, an antibody-drug conjugate, in relapsed/refractory CD25-positive acute myeloid leukemia or acute lymphoblastic leukemia: A phase I study

Year: 2020

Type: article

Study design: Clinical Trial

Source: Leukemia Research

DOI: 10.1016/j.leukres.2020.106385

Authors: Aaron D. Goldberg, Ehab Atallah, David Rizzieri, Roland B. Walter, Ki-Young Chung, Alexander Spira, Wendy Stock, Martin S. Tallman, Hans G. Cruz, Joseph Boni, Karin E.G. Havenith, Grace Chao, Jay M. Feingold, Jens Wuerthner, Melhem Solh

Institutions: Memorial Sloan Kettering Cancer Center, Medical College of Wisconsin, Duke Medical Center, Fred Hutch Cancer Center, Prisma Health, Virginia Cancer Specialists, University of Chicago, Adc Therapeutics (Switzerland), Northside Hospital

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3033706053

FWCI: 3.507

Cites: 40

Cited by: 41

Related to: 10